28.7 C
New York
Friday, June 12, 2026

Tag: fat

newssourceFORcompanyinformationcontent1marketreleases

Fit After 50, a Wellness-Focused Training System by Live Anabolic, Gains National Attention: Age-Defying Fitness Strategy Redefines Strength and Vitality for Men Over 50

Exploring the Growing Demand for Safe, At-Home Workouts That Support Strength, Hormonal Balance, and Longevity in Men Over 50 
Exploring the Growing Demand for Safe, At-Home Workouts That Support Strength, Hormonal Balance, and Longevity in Men Over 50

Prism Pain and Wellness Offering Novel Brain Stimulation to Treat Depression and Optimize Mental Health

ENGLEWOOD, Colo., June 26, 2025 /PRNewswire/ -- The pinnacle of medication-free wellness is now available for those struggling with depression, anxiety and mental fog....

Altimmune to Announce Topline 24 Week Results from its IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH on Thursday, June 26

Company to host Investor Webcast on Thursday, June 26, 2025, at 8:30 am E.T. 
Company to host Investor Webcast on Thursday, June 26, 2025, at 8:30 am E.T.

Liver Disease Treatments: Global Market Forecast and Emerging Trends Through 2030

"Rising liver disease cases and biotech innovations are fueling demand for advanced therapies, with personalized medicine and fibrosis-targeting treatments shaping the global market landscape." BOSTON,...

Liver Disease Treatments: Global Market Forecast and Emerging Trends Through 2030

"Rising liver disease cases and biotech innovations are fueling demand for advanced therapies, with personalized medicine and fibrosis-targeting treatments shaping the global market landscape." BOSTON,...

Nano Earth Labs Keto ACV Gummies Website Update Introduces Consumer Tools for Daily Ketogenic Supplementation Support

Nano Earth Labs Keto ACV Gummies featured in updated official website rollout with consumer tools, subscription options, and ketogenic support information. 
Nano Earth Labs Keto ACV Gummies featured in updated official website rollout with consumer tools, subscription options, and ketogenic support information.

FORM50 SET TO OPEN NEW BOCA RATON STUDIO THIS SUMMER

The It-Girl, Go-To Reformer Strength Training Brand Expands to Its Fifth Location BOCA RATON, Fla., June 24, 2025 /PRNewswire/ -- FORM50 Fitness, the high-intensity, low-impact...

High-End Electrics: Fancy Toys, Empty Pockets

The Mercedes G-Class electric SUV might have been hyped for its off-road prowess and flashy features like tank turns, but reality bites: sales are...

Davis Commodities Limited Announces Results of Extraordinary General Meeting

Davis Commodities' EGM approves share reclassification, Amended M&A adoption, and flexibility for future share capital adjustments.

Pals Health Redefines Supplement Standards with Clinically Proven Ingredients and Exceptional Bioavailability

TOMS RIVER, N.J., June 20, 2025 /PRNewswire/ -- In a supplement market saturated with empty promises and low-quality formulations, Pals Health emerges as a brand committed to...

BrightGene Presents Positive Phase 2 Data for Dual GLP-1R/GIPR Agonist for Weight Management and Type 2 Diabetes and Preclinical Data for Novel Amylin Analog...

Phase 2 data highlights best-in-class potential of dual GLP-1R/GIPR agonist BGM0504 for weight management and metabolic risk reduction in individuals with type 2 diabetes...

BrightGene Presents Positive Phase 2 Data for Dual GLP-1R/GIPR Agonist for Weight Management and Type 2 Diabetes and Preclinical Data for Novel Amylin Analog...

Phase 2 data highlights best-in-class potential of dual GLP-1R/GIPR agonist BGM0504 for weight management and metabolic risk reduction in individuals with type 2 diabetes...

BrightGene Presents Positive Phase 2 Data for Dual GLP-1R/GIPR Agonist for Weight Management and Type 2 Diabetes and Preclinical Data for Novel Amylin Analog...

Phase 2 data highlights best-in-class potential of dual GLP-1R/GIPR agonist BGM0504 for weight management and metabolic risk reduction in individuals with type 2 diabetes...

BrightGene Presents Positive Phase 2 Data for Dual GLP-1R/GIPR Agonist for Weight Management and Type 2 Diabetes and Preclinical Data for Novel Amylin Analog...

Phase 2 data highlights best-in-class potential of dual GLP-1R/GIPR agonist BGM0504 for weight management and metabolic risk reduction in individuals with type 2 diabetes...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFat

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers